🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Insurance denied me AGAIN - I am so frustrated Page 4

Insurance denied me AGAIN - I am so frustrated

InsuranceTom Wed, Dec 17, 2025 at 11:39 PM 22 replies 902 viewsPage 4 of 5
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Dec 18, 2025 at 5:19 AM#16

Just wanted to say — for anyone reading this Insurance denied me thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

24 1sarah_TO, wendy_avl, jason_paloalto and 21 others
Reply Quote Save Share Report
KristenIndy
Member
623
2,678
May 2024
Indianapolis, IN
Dec 18, 2025 at 5:36 AM#17

InsuranceTom's experience with Insurance denied me AGAIN resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I titrated faster. But the overall trajectory has been remarkably similar. Down 40 lbs in 5 months.

One thing I would add that InsuranceTom did not mention: the relationship with food fundamentally changed.

2 7amsterdam_pete, LondonLisa
Reply Quote Save Share Report
tane_welly
Member
234
1,123
Sep 2024
Wellington, NZ
Dec 18, 2025 at 5:53 AM#18

Saving this for reference. Quality thread.

Last edited: Dec 18, 2025 at 8:53 AM
33 21DanielChem_CHI, marco_milano, pam_columbus and 30 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Dec 18, 2025 at 6:10 AM#19

As a healthcare provider, I want to add some clinical context to this discussion on Insurance denied me AGAIN - I am so.

Building on what InsuranceTom said — the evidence base here is well-established. The key publications to reference are from the SUSTAIN program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
39 2Dr.SurgeonPGH, rachel_ABQ, traveltech_sara and 36 others
Reply Quote Save Share Report
RetaRick_CA
VIP Member
2,012
9,876
Jan 2024
California
Dec 18, 2025 at 6:27 AM#20

Subscribing to this thread. Insurance denied me AGAIN is exactly what I've been researching. 🙏

25 5MounjBrad, nick_newbie, DadBodDave and 22 others
Reply Quote Save Share Report

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register